Florence Anthony A. Jr.

Average Profitability
<0.0001%
Insider Buys Quantity
24
Insider Buys Sum
$307.91M
Insider Sells Quantity
8
Insider Sells Sum
$132.61M

Insider Activity of Florence Anthony A. Jr.

According to the SEC Form 4 filings, Florence Anthony A. Jr., being in a position of

  1. 10 percent owner at Korro Bio, Inc.,
    оver the last 12 months, has bought 17857 shares for $999,992, and sold 0 shares,
    over all time since 2024-04-22, has bought 17857 shares for $999,992, and sold 0 shares.

The largest purchase of all time was on 2018-09-07 and amounted to 30000000 shares of Adaptimmune Therapeutics plc for $50M.

The largest sale of all time was on 2017-11-20 and amounted to 5641032 shares of Appian Corporation for $109.94M.

Biography of Florence Anthony A. Jr.

No biography is available at this moment.

2024-04-22PurchaseKorro Bio, Inc.
KRRO
10 percent owner
17,857
0.205%
$56.00$999,992-31.3%
2023-07-17PurchaseSavara Inc.
SVRA
10 percent owner
333,333
0.2084%
$3.00$999,999+32.17%
2022-12-21SaleArcellx, Inc.
ACLX
director
179
0.0005%
$30.74$5,502+9.86%
2022-05-03SaleRobinhood Markets, Inc.
HOOD
director
1,952
0.0002%
$10.06$19,640-5.45%
2022-05-02SaleRobinhood Markets, Inc.
HOOD
1,952
0.0002%
$10.06$19,640-8.78%
2022-04-11PurchaseTrevi Therapeutics, Inc.
TRVI
948,948
1.1133%
$1.90$1.8M-15.26%
2022-01-31SaleRobinhood Markets, Inc.
HOOD
director
4,164
0.0005%
$14.22$59,195-29.75%
2021-10-18PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
3.7M
11.1305%
$0.81$3M+63.35%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.05M
20.5778%
$19.00$19.95M-7.95%
2021-03-16PurchaseMarker Therapeutics, Inc.
MRKR
10 percent owner
5.71M
9.5207%
$1.75$10M-4.3%
2020-12-04PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
4.4M
7.578%
$0.62$2.74M+22.37%
2020-07-28PurchaseInozyme Pharma, Inc.
INZY
10 percent owner
250,000
1.2168%
$16.00$4M+19.03%
2020-07-14PurchaseNkarta, Inc.
NKTX
10 percent owner
1.33M
2.1488%
$18.00$24M-11.28%
2020-04-13SaleMersana Therapeutics, Inc.
MRSN
10 percent owner
41,828
0.0683%
$8.50$355,551+128%
2020-04-03SaleTrevi Therapeutics, Inc.
TRVI
10 percent owner
1,128
0.0062%
$2.66$3,000+19.07%
2020-01-24PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
7.5M
1.0346%
$0.67$5M+34.69%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
5.3814%
$15.00$13.5M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
34.6117%
$10.00$50M-42.9%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
1.14M
6.1239%
$1.08$1.23M-40%
2018-09-07PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
30M
4.8721%
$1.67$50M-57.66%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.